BRAF mutant gastrointestinal stromal tumor: first report of regression with BRAF inhibitor dabrafenib (GSK2118436) and whole exomic sequencing for analysis of acquired resistance (Q37016582)
Jump to navigation
Jump to search
scientific article published on February 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | BRAF mutant gastrointestinal stromal tumor: first report of regression with BRAF inhibitor dabrafenib (GSK2118436) and whole exomic sequencing for analysis of acquired resistance |
scientific article published on February 2013 |
Statements
1 reference
BRAF mutant gastrointestinal stromal tumor: first report of regression with BRAF inhibitor dabrafenib (GSK2118436) and whole exomic sequencing for analysis of acquired resistance (English)
1 reference
G S Falchook
1 reference
J C Trent
1 reference
M C Heinrich
1 reference
C Beadling
1 reference
J Patterson
1 reference
C C Bastida
1 reference
S C Blackman
1 reference
R Kurzrock
1 reference
1 February 2013
1 reference
1 reference
310-315
1 reference
Identifiers
1 reference
1 reference